Lucchino David L.'s Form 4 filing
Korro Bio, Inc. (KRRO) · filed Jul 7, 2023
- Accession no.
- 0001127602-23-020474
- Filed
- Jul 7, 2023, 4:56 PM ET
- Trade date
- Jul 5-6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $942.82. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0000950170-23-032731 (Jul 12, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lucchino David L.CIK 0001785288 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 5, 2023 | Common Stock | MOption exerciseAcquired | +9,091 | –F1 | – | 432,512 | Direct | |
| Jul 6, 2023 | Common Stock | SSaleDisposed | −2,773 | $0.34F3 | −$942.82 | 429,739 | Direct | |
| Jul 6, 2023 | Common Stock | MOption exerciseAcquired | +9,091 | –F1 | – | 438,830 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive on share of Issuer common stock.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.
- F3
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.33 to $0.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Referenced by the price of 1 transaction in Table I.